<DOC>
	<DOCNO>NCT00246987</DOCNO>
	<brief_summary>To determine effect glycemic control lipid parameter 2.5 5 mg. dos BMS-298585 drug naive subject Type 2 diabetes adjunct diet exercise .</brief_summary>
	<brief_title>A Trial Evaluate BMS-298585 Monotherapy Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Subjects Type 2 diabetes Drug Naive HbA1c &gt; = 7.0 % &lt; = 10.0 % Body Mass Index &lt; = 41 kg/m2 Serum TG &lt; = 600 mg/dL Symptomatic Type 2 diabetes History bladder cancer History Myocardial Infarction ( MI ) , coronary angioplasty bypass graft , valvular disease repair , unstable angina pectoris , Transient Ischemic Attach ( TIA ) , Cerebrovascular Accident ( CVA ) within 6 month , congestive heart failure ( NYHA Class II IV ) , uncontrolled hypertension , history renal disease , peripheral vascular disease ( PVD ) , pulmonary disease , gastrointestinal disease , active liver disease endocrine disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2012</verification_date>
</DOC>